Hu Ye, Bajorath Jürgen
Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany.
F1000Res. 2013 Jun 27;2:144. doi: 10.12688/f1000research.2-144.v2. eCollection 2013.
Compound promiscuity is defined as the ability of a small molecule to specifically interact with multiple biological targets. So-defined promiscuity is relevant for drug discovery because it provides the molecular basis of polypharmacology, which is increasingly implicated in the therapeutic efficacy of drugs. Recent studies have analyzed different aspects of compound promiscuity on the basis of currently available activity data. In this commentary, we present take-home messages from these studies augmented with new results to generate a detailed picture of compound promiscuity that might serve as a reference for further discussions and research activities.
化合物多配体性被定义为小分子与多个生物靶点特异性相互作用的能力。如此定义的多配体性与药物发现相关,因为它提供了多药理学的分子基础,而多药理学越来越多地与药物的治疗效果相关。最近的研究基于现有的活性数据分析了化合物多配体性的不同方面。在这篇评论中,我们展示了这些研究的关键信息,并补充了新的结果,以生成一幅关于化合物多配体性的详细图景,这可能为进一步的讨论和研究活动提供参考。